UPDATE FROM TGA: Serious Scarcity Substitution Instrument (SSSI) for warfarin

The TGA has made a Serious Scarcity Substitution Instrument (SSSI) for warfarin.  This instrument is in force until 07 August 2023 and allows a pharmacist to offer the patient or their carer a lower strength of COUMADIN warfarin tablet if the 5mg tablet is unavailable, without prior approval from the prescriber.

The TGA SSSI website provides information to pharmacists, prescribers and patients. The web alert includes a link to a printable PDF patient information sheet that pharmacists may find useful when counselling patients who are dispensed a substitutable medicine. Viatris, the sponsor of COUMADIN tablets will also be disseminating this information sheet.

The substitution has PBS subsidy arrangements, and the PBS website has been updated with this information.

If you have any questions, please contact the Medicine Shortages Section on 02 6289 4646 or email [email protected].

Abstract closed for CSANZ NZ ASM

 

Join us for the much anticipated CSANZ NZ ASM. Get the team together and head to Auckland in June for 2.5 days of expert lecturers, hands-on workshops, nursing symposium and a range of scientific sessions that will take your knowledge to the next level!

Catch up with old friends and meet new colleagues at the various social activities.  Boost your career by presenting your research at the 2023 CSANZ NZ ASM – submit your abstract now!

ABSTRACTS CLOSE ON MONDAY 13 MARCH AT 7PM (NZDT)

Ever wondered who was R.T. Hall, the namesake of the Lecture that launches every CSANZ Annual Scientific Meeting?

R.T. Hall came to Sydney from England in 1853 on the vessel “Waterloo”.

He was consumptive but managed to survive the long voyage and made a complete recovery.  His affairs flourished and after he died in 1894, a trust was established initially for: “An invalid home for the reception, cure and treatment of culture for respectable, moral persons, residing in Sydney or its suburbs, and suffering from consumption of the lungs”.

A sanitarium was established in the Blue Mountains in 1909 and was active till the early 1950s when the treatment of tuberculosis radically changed. The trust then looked for an alternative field to support and became involved in The National Heart Foundation. In 1959 and for a number of years, the bequest supported the RT Hall Lecturer.  However, in more recent times, the bequest has supported the RT Hall Prize and the lectureship has been funded by a donation from The National Heart Foundation, for which we are very grateful.

Register for the next CSANZ ASM here

Warfarin shortage in Australia – Update 2 March 2023

We are currently in consultation with TGA, and understand that there are a number of shortages including:

  • Coumadin 5 mg tablets until end of July
  • Coumadin 2 mg tablets until end of April
  • Marevan 3 mg tablets until 10 March 2023

TGA are actively working with suppliers and chemists to ensure that appropriate stocks remain. We are aware that some patients are attending multiple pharmacies and that some patients may have to undertake a temporary substitution in either formulation or individual tablet dosage.  This may require more frequent monitoring and we have communicated to the media that patients should consult with their prescribing doctor.

We have strongly advocated to TGA the importance of warfarin to many patients, and have requested that they investigate approaches which permit them to communicate to patients where warfarin is accessible.

We’ll keep you posted with any more developments.

2022 CSANZ ASM Prize winners

Congratulations to all the 2022 ASM Prize Winners

Allied Health, Science and Technology Prize
Winner:  Adam Livori, Ballarat Health Services

Assessment of Telehealth Cardiology Pharmacist Clinic in Improving Therapy Adherence following Acute Coronary Syndrome and PCI.
 
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: Judith Katzenellenbogen, Andrew Maiorana, Katrina Poppe

Cardiac Imaging Prize
Winner:  Aaisha Ferkh, Westmead Hospital

Echocardiographic deep phenotyping of hypertrophic cardiomyopathies: amyloid, Anderson-Fabry and hypertensive heart disease.
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: Selwyn Wong, Raj Puranik, Rebecca Kozor

Cardiovascular Nursing Prize
Winner:  Kristel Janssens, Baker Heart and Diabetes Institute

Modest association between peak exercise blood pressure and ambulatory hypertension in endurance athletes.
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: Patricia Davidson, Kimberley Bardsley, Christopher Lee

Heart Failure Prize
Winner:  David Chieng, Baker Heart and Diabetes Institute

Catheter ablation in atrial fibrillation and heart failure with preserved ejection fraction improves peak pulmonary capillary wedge pressure, exercise capacity and quality of life. A Prospective Randomised Controlled Trial (RCT-STALL HFpEF).
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: Andrew Sindone, Rob Doughty, Theresa McDonagh

Heart Rhythm Prize
Winner:  Ahmed Al-Kaisey, Royal Melbourne Hospital

Polygenic risk scores identify atrial electrophysiological substrate abnormalities and predict atrial fibrillation recurrence following catheter ablation.
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: Andrew Martin, Livia Hool, Karen Phillips

Indigenous Health Prize
Winner:  Keriana Kingi-Nepe, Gisborne Hospital NZ

The impact of Sacubitril-Valsartan on Te Tairāwhiti (Gisborne and East Coast) region.
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: Alex Brown, Karen Brewer

Paediatric and Congenital Cardiology Prize
Winner:  Elizabeth Paratz, Baker Heart and Diabetes Institute

Prevalence of coronary artery anomalies in young sudden cardiac death: insights from a prospective state-wide registry.
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: Clare O’Donnell, Mugur Nicolae

Prevention Prize
Winner:  Louise Segan, Baker Heart and Diabetes Institute

Development and validation of the HARMS2-AF lifestyle risk score to predict incident AF.
Read abstract in full as published in Heart Lung and Circulation Journal.

Judges: David Colquhoun, Julie Redfern, Robyn Gallagher

2022 CSANZ ASM New Investigator Poster Prizes

Medical Student Poster Prize
Winner:  Angus Fung, UNSW

Title: Prognostic association supports indexing size measures in echocardiography by body surface area.

Judges: Peter Psaltis and Dominica Zentner

Basic Physician Trainee or Advanced Trainee Poster Prize 
Winner:  Gavin Huangfu, Fiona Stanley Hospital

Title:  CT evaluation of hepatic fat: A novel marker for high-risk coronary atherosclerosis in Familial Hypercholesterolaemia.

Judges: Matthew Worthley, Liza Thomas

PhD Candidate Poster Prize 
Winner: Himawan Fernando, Alfred Health

Title: LidocAine Versus Opioids In MyocarDial infarction: The AVOID-2 randomised controlled trial.

Judges: Clara Chow, Will Parsonage

Cardiovascular Nursing Poster Prize 
Winner:  Nathan Herbert, Barwon Health

Title: Impact of COVID-19 pandemic lockdown on a Victorian regional ST-elevation myocardial infarction service.

Judges: Caleb Ferguson, Rochelle Wynne 

Allied Health, Science and Technology Poster Prize
Winner:  Clara Zwack, University of Sydney

Stress and its relationship to cardiovascular risk in young adults with intellectual disability

Judges: Lee Nedkoff, Stacey Nielson

Congratulations to all finalists in the prize sessions and thank you to all the judges.

Australia Day Awards 2023 – Congratulations!

We are very proud to announce the following Australia Day 2023 Honour List Awards to two of our members.

*Prof Clara Chow AM, Immediate Past President, FCSANZ has been awarded a Member of the Order of Australia, (AM) for her significant service to medicine as a cardiologist, and to research.

*Prof Gemma Figtree AM, FCSANZ, also awarded a Member of the Order of Australia (AM) for her significant service to medicine in the field of cardiology.

View a message of congratulations from CSANZ President, Prof Stephen Nicholls including a brief outline of the fabulous work these two women in cardiology have achieved thus far.

Congratulations to you both!

* citation excepts above taken from the Honour List Awards announcement on www.gg.gov.au/20230126 – Media Notes – AM (A-L)  

Prestigious Anitschkow Prize Awarded to Prof Stephen Nicholls

Congratulations to CSANZ Chair, Prof Stephen Nicholls for winning the prestigious 2023 Anitschkow Prize of the European Atherosclerosis Society (EAS).

The Anitschkow Prize is the most prestigious distinction in atherosclerosis research, named after Nikolai Anitschkow who performed the first foundational study, feeding rabbits a cholesterol rich diet and observing the formation of plaques in the aortic wall.

This award recognises Prof Nicholls’ outstanding contributions to atherosclerosis, cardiometabolic disease and preventive cardiology Including elucidating the factors influencing the functionality of high-density lipoproteins; understanding the factors influencing plaque progression and regression; as well as leadership of clinical trials of novel cardioprotective therapies.

Read more here

Prof Nicholls will receive the Anitschkow Medal and is invited to present the Anitschkow Lecture at the Opening Ceremony of the #EASCongress2023  in Manheim Germany, 21 May 2023.

Posts navigation